Benefit Risk Evaluation Assessor – Decontamination & Infection Control

The MHRA is transforming. Through enabling innovation, making the right judgements of the benefits and risks of medical products and forging the right partnerships in the UK and internationally, it aims to deliver world class regulation and improved outcomes for UK patients.

We are currently looking for experienced Benefit Risk Evaluation Assessor to join our Benefit/Risk Evaluation Team I in the Safety and Surveillance group.

Within a week of working here, your day could look like this: Actively participate in meetings and work programmes to assess and investigate safety signals involving sterilisation; effective management of safety issues ensuring relevant assessors are kept up-to-date and quality of work is maintained.

You will provide specialist technical advice and support on sterilisation to other colleagues and senior officials to meet divisional business needs and targets. As well as undertake technical reviews of sterilisation issues as required on new and emerging safety signals and/or new and emerging data/evidence and make recommendations for actions to protect patients.

The successful candidate will have a degree or equivalent qualification in life sciences, health care or engineering (such as medical engineering, toxicology, material science, or healthcare qualification); and previous relevant experience gained in healthcare, medical device manufacturing, regulatory environment, or health data science.

Our successful candidate will have:

• Knowledge or practical experience of medical devices
• Experience of critically analysing complex clinical/scientific/technical information from a number of sources under pressure and make appropriate recommendations or decisions to protect patient safety/public health even when the evidence is not clear. Implement appropriate actions to mitigate risk
• Evidence of writing well-structured, concise, reports to support decision making and provide information to stakeholders.
• Awareness of the regulatory frameworks

Closing date: 12 April 2026